These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32707526)

  • 1. Structure-based design of covalent inhibitors targeting metallo-β-lactamases.
    Chen C; Yang KW
    Eur J Med Chem; 2020 Oct; 203():112573. PubMed ID: 32707526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The assemblage of covalent and metal binding dual functional scaffold for cross-class metallo-β-lactamases inhibition.
    Chen C; Liu Y; Zhang YJ; Ge Y; Lei JE; Yang KW
    Future Med Chem; 2019 Sep; 11(18):2381-2394. PubMed ID: 31544522
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent advances in the discovery of metallo-β-lactamase inhibitors for β-lactam antibiotic-resistant reversing agents.
    Guo Z; Ma S
    Curr Drug Targets; 2014; 15(7):689-702. PubMed ID: 24666360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time activity assays of β-lactamases in living bacterial cells: application to the inhibition of antibiotic-resistant E. coli strains.
    Ge Y; Zhou YJ; Yang KW; Zhang YL; Xiang Y; Zhang YJ
    Mol Biosyst; 2017 Oct; 13(11):2323-2327. PubMed ID: 28906528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A focused fragment library targeting the antibiotic resistance enzyme - Oxacillinase-48: Synthesis, structural evaluation and inhibitor design.
    Akhter S; Lund BA; Ismael A; Langer M; Isaksson J; Christopeit T; Leiros HS; Bayer A
    Eur J Med Chem; 2018 Feb; 145():634-648. PubMed ID: 29348071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress toward inhibitors of metallo-β-lactamases.
    McGeary RP; Tan DT; Schenk G
    Future Med Chem; 2017 May; 9(7):673-691. PubMed ID: 28504895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxamic acid with benzenesulfonamide: An effective scaffold for the development of broad-spectrum metallo-β-lactamase inhibitors.
    Li JQ; Chen C; Yao M; Sun LY; Gao H; Chigan J; Yang KW
    Bioorg Chem; 2020 Dec; 105():104436. PubMed ID: 33171408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Continuing Challenge of Metallo-β-Lactamase Inhibition: Mechanism Matters.
    Ju LC; Cheng Z; Fast W; Bonomo RA; Crowder MW
    Trends Pharmacol Sci; 2018 Jul; 39(7):635-647. PubMed ID: 29680579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A protein structure-guided covalent scaffold selectively targets the B1 and B2 subclass metallo-β-lactamases.
    Chen C; Xiang Y; Yang KW; Zhang Y; Wang WM; Su JP; Ge Y; Liu Y
    Chem Commun (Camb); 2018 May; 54(38):4802-4805. PubMed ID: 29687124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and Mechanism-Guided Design of Dual Serine/Metallo-Carbapenemase Inhibitors.
    Chen C; Oelschlaeger P; Wang D; Xu H; Wang Q; Wang C; Zhao A; Yang KW
    J Med Chem; 2022 Apr; 65(8):5954-5974. PubMed ID: 35420040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Cisplatin and Palladium(II) Complexes as Potent Metallo-β-lactamase Inhibitors for Targeting Carbapenem-Resistant
    Chen C; Sun LY; Gao H; Kang PW; Li JQ; Zhen JB; Yang KW
    ACS Infect Dis; 2020 May; 6(5):975-985. PubMed ID: 32119777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase Inhibitors.
    Cain R; Brem J; Zollman D; McDonough MA; Johnson RM; Spencer J; Makena A; Abboud MI; Cahill S; Lee SY; McHugh PJ; Schofield CJ; Fishwick CWG
    J Med Chem; 2018 Feb; 61(3):1255-1260. PubMed ID: 29271657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Halogen-Substituted Triazolethioacetamides as a Potent Skeleton for the Development of Metallo-β-Lactamase Inhibitors.
    Zhang Y; Yan Y; Liang L; Feng J; Wang X; Li L; Yang K
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30934584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipyridyl-substituted thiosemicarbazone as a potent broad-spectrum inhibitor of metallo-β-lactamases.
    Li JQ; Gao H; Zhai L; Sun LY; Chen C; Chigan JZ; Ding HH; Yang KW
    Bioorg Med Chem; 2021 May; 38():116128. PubMed ID: 33862468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a novel covalent non-β-lactam inhibitor of the metallo-β-lactamase NDM-1.
    Christopeit T; Albert A; Leiros HS
    Bioorg Med Chem; 2016 Jul; 24(13):2947-2953. PubMed ID: 27184103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metallo-β-lactamases: structural features, antibiotic recognition, inhibition, and inhibitor design.
    Wang JF; Chou KC
    Curr Top Med Chem; 2013; 13(10):1242-53. PubMed ID: 23647546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ruthenium complexes as prospective inhibitors of metallo-β-lactamases to reverse carbapenem resistance.
    Chen C; Yang K
    Dalton Trans; 2020 Oct; 49(40):14099-14105. PubMed ID: 32996954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total Synthesis and Activity of the Metallo-β-lactamase Inhibitor Aspergillomarasmine A.
    Koteva K; King AM; Capretta A; Wright GD
    Angew Chem Int Ed Engl; 2016 Feb; 55(6):2210-2. PubMed ID: 26709849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure, Function of Serine and Metallo-β-lactamases and their Inhibitors.
    Salahuddin P; Kumar A; Khan AU
    Curr Protein Pept Sci; 2018; 19(2):130-144. PubMed ID: 28745223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in β-lactamase inhibitor chemotypes and inhibition modes.
    Li R; Chen X; Zhou C; Dai QQ; Yang L
    Eur J Med Chem; 2022 Nov; 242():114677. PubMed ID: 35988449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.